📗 Cite This Artifact
mch-receptor-neurons
Melanin-Concentrating Hormone (MCH) Receptor Neurons
Introduction
Mch Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Melanin-concentrating hormone (MCH) receptor neurons represent a critical hypothalamic system involved in energy homeostasis, sleep-wake regulation, mood modulation, and increasingly recognized roles in neuroprotection and neurodegenerative diseases. MCH signals through two G protein-coupled receptors, MCHR1 and MCHR2, with distinct but overlapping expression patterns in the brain. The MCH system has emerged as a therapeutic target for metabolic disorders, sleep disturbances, depression, and potentially neurodegenerative conditions including Alzheimer's disease (AD) and Parkinson's disease (PD). This comprehensive page explores the molecular biology, neuroanatomy, physiological functions, and disease relevance of MCH receptor neurons. [@bittencourt2020]
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197) | sensory receptor cell |
Morphology & Electrophysiology
- Morphology: melanin-concentrating hormone neuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
External Database Links
...
Melanin-Concentrating Hormone (MCH) Receptor Neurons
Introduction
Mch Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Melanin-concentrating hormone (MCH) receptor neurons represent a critical hypothalamic system involved in energy homeostasis, sleep-wake regulation, mood modulation, and increasingly recognized roles in neuroprotection and neurodegenerative diseases. MCH signals through two G protein-coupled receptors, MCHR1 and MCHR2, with distinct but overlapping expression patterns in the brain. The MCH system has emerged as a therapeutic target for metabolic disorders, sleep disturbances, depression, and potentially neurodegenerative conditions including Alzheimer's disease (AD) and Parkinson's disease (PD). This comprehensive page explores the molecular biology, neuroanatomy, physiological functions, and disease relevance of MCH receptor neurons. [@bittencourt2020]
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197) | sensory receptor cell |
Morphology & Electrophysiology
- Morphology: melanin-concentrating hormone neuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
External Database Links
- [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
- [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
Molecular Biology of MCH Receptors
MCHR1 (Melanin-Concentrating Hormone Receptor 1)
MCHR1, also known as GPR24, is a 353-amino acid G protein-coupled receptor primarily coupled to Gq proteins, leading to activation of phospholipase C (PLC) and subsequent intracellular calcium mobilization. MCHR1 is expressed predominantly in the central nervous system, with highest expression in the hypothalamus, nucleus accumbens, and cerebral cortex. [@shimazaki2021]
Signal Transduction Pathways: [@luber2020]
- Gq/PLC Pathway: MCHR1 activates phospholipase C-beta, generating inositol trisphosphate (IP3) and diacylglycerol (DAG), leading to protein kinase C (PKC) activation and intracellular calcium release.
- MAPK Activation: MCHR1 signaling stimulates mitogen-activated protein kinase (MAPK) pathways, including ERK1/2 phosphorylation.
- Arrestin Recruitment: MCHR1 undergoes β-arrestin-dependent signaling, contributing to receptor desensitization and alternative downstream effects.
MCHR2 (Melanin-Concentrating Hormone Receptor 2)
MCHR2 is a more recently identified receptor that shares approximately 31% amino acid identity with MCHR1. Importantly, MCHR2 is functional in humans but not in rodents, complicating translational research. [@kong2022]
Species Distribution: [@gao2021]
- Human: Functional MCHR2 expressed in hypothalamus, cortex, and peripheral tissues.
- Mouse/Rat: MCHR2 is a pseudogene, limiting preclinical research to MCHR1-focused studies.
MCH Peptide
The MCH peptide is a 19-amino acid cyclic neuropeptide derived from pre-pro-melanin-concentrating hormone (pre-pro-MCH), encoded by the PMCH gene. MCH is primarily produced in neurons of the lateral hypothalamus and zona incerta, with projections throughout the brain. [@schwartz2020]
Processing: The pre-pro-MCH precursor is processed to generate MCH and several other neuropeptides including neuropeptide E-I (NEI) and neuropeptide G-E (NGE), which may have distinct biological activities. [@ollmann2021]
Neuroanatomical Distribution
MCH Neuron Cell Bodies
MCH-producing neurons are concentrated in:
Lateral Hypothalamus (LH): The primary site of MCH neuron cell bodies, the lateral hypothalamus contains MCH neurons that project extensively to wake-promoting regions. These neurons are active during REM sleep and promote sleep entry.
Zona Incerta (ZI): A second major population of MCH neurons resides in the zona incerta, which projects to thalamic and brainstem targets involved in arousal and motivation.
Incerto-hypothalamic Area: A continuum of MCH neurons connecting the lateral hypothalamus to the zona incerta.
MCHR1 Expression
MCHR1 is widely distributed throughout the brain:
Hypothalamic Regions:
- Arcuate nucleus (ARC): Modulates energy homeostasis and neuroendocrine function
- Paraventricular nucleus (PVN): Regulates stress responses and autonomic function
- Preoptic area: Involved in sleep regulation
- Nucleus accumbens (NAc): Particularly the shell region, involved in reward and motivation
- Amygdala: Modulates emotional processing and fear responses
- Hippocampus: Involved in memory consolidation and plasticity
- Layer 6 corticothalamic pyramidal neurons: Express MCHR1 and receive MCH inputs
- Prefrontal cortex: Involved in executive function and decision-making
- Olfactory bulb: Mitral and granule cells express MCHR1
- Brainstem: Spinal trigeminal nucleus, dorsal raphe nucleus
- Thalamus: Various relay nuclei
MCHR2 Expression
MCHR2 shows more limited distribution, with expression in:
- Hypothalamus (lateral and paraventricular nuclei)
- Cortex (primarily frontal and temporal regions)
- Peripheral tissues (gut, pancreas, adipose tissue)
Physiological Functions
Energy Homeostasis and Metabolism
MCH receptor signaling plays a crucial role in regulating energy balance:
Food Intake: MCH is orexigenic (appetite-stimulating). MCH neuron activation increases food intake, while MCH deficiency reduces feeding. MCHR1 antagonists have been investigated as anti-obesity agents.
Energy Expenditure: MCH modulates metabolic rate and thermogenesis. MCH-deficient mice are lean and resistant to diet-induced obesity due to increased energy expenditure.
Glucose Metabolism: MCH receptor signaling influences insulin sensitivity and glucose homeostasis. MCHR1 antagonists improve glycemic control in preclinical models.
Body Weight: Chronic MCH signaling promotes weight gain, while MCH receptor blockade reduces body weight in obese animal models.
Sleep-Wake Regulation
MCH neurons are primarily active during sleep, particularly REM sleep:
REM Sleep Promotion: MCH neurons fire maximally during REM sleep and promote REM sleep entry and maintenance. MCH infusion into the brain increases REM sleep time.
Sleep Architecture: MCH modulates the cycling between sleep stages, particularly the transition from non-REM to REM sleep.
Arousal Modulation: MCH inputs to wake-promoting regions (orexin neurons, locus coeruleus, dorsal raphe) may inhibit arousal systems during sleep.
Mood and Emotion
MCH receptor signaling influences affective states:
Depression: MCHR1 antagonists have demonstrated antidepressant-like effects in preclinical models, potentially through modulation of monoaminergic systems.
Anxiety: MCH may have anxiogenic effects, with MCHR1 blockade reducing anxiety-like behaviors.
Motivation and Reward: MCH projections to the nucleus accumbens modulate reward processing and motivation, relevant to addiction and anhedonia.
Cognitive Function
MCH influences several cognitive domains:
Learning and Memory: MCHR1 is expressed in hippocampal CA2/CA3 regions and the entorhinal cortex. MCH signaling modulates hippocampal synaptic plasticity and memory consolidation.
Executive Function: Prefrontal cortex MCHR1 influences working memory and decision-making.
Role in Neurodegenerative Diseases
Alzheimer's Disease
The MCH system has several connections to Alzheimer's disease pathology and symptoms:
Amyloid Pathology:
- MCH neurons may be vulnerable to amyloid-beta toxicity
- MCH modulation of neuronal excitability could influence amyloid-induced network dysfunction
- Some studies suggest MCH may interact with amyloid precursor protein (APP) processing
- MCH neurons in the lateral hypothalamus show vulnerability in tauopathies
- Tau pathology in MCH neurons correlates with sleep disturbances in AD
- MCH system dysfunction may contribute to sleep fragmentation in AD
- Disrupted MCH signaling could exacerbate memory consolidation deficits
- MCH modulation of hippocampal circuits may affect spatial memory
- MCHR1 antagonists may improve cognitive function in AD
- Targeting MCH could address sleep disturbances common in AD patients
- MCH's effects on neuroinflammation may be relevant to AD progression
Parkinson's Disease
MCH involvement in Parkinson's disease includes:
Non-Motor Symptoms:
- Sleep disorders in PD (REM sleep behavior disorder, insomnia) may involve MCH dysfunction
- Depression and anxiety in PD could relate to MCH system alterations
- Autonomic dysfunction (including metabolic disturbances) may involve MCH
- MCH interactions with dopamine systems could influence motor function
- MCH modulation of basal ganglia circuits may affect levodopa-induced dyskinesias
- Some evidence suggests MCH may have neuroprotective properties
- MCH receptor modulation could protect dopaminergic neurons
Other Neurodegenerative Disorders
Huntington's Disease:
- MCH system alterations have been reported in HD models
- Sleep disturbances in HD may involve MCH dysfunction
- MCHR1 modulation may influence striatal circuit function
- Autonomic dysfunction in MSA may involve MCH
- Sleep disorders in MSA could relate to MCH system changes
Clinical and Therapeutic Implications
Therapeutic Targets
MCH receptors represent potential drug targets for several conditions:
Obesity and Metabolic Disorders:
- MCHR1 antagonists (e.g., SNAP-7941, ATC0065) reduce food intake and body weight
- Several compounds advanced to clinical trials for obesity treatment
- Challenges include achieving brain penetration and avoiding side effects
- MCHR1 agonists could promote sleep, particularly REM sleep
- Potential applications for insomnia and sleep maintenance
- MCH-based therapies could address sleep fragmentation in neurodegeneration
- MCHR1 antagonists show antidepressant and anxiolytic potential
- May work through modulation of monoamine systems
- Could be particularly relevant for treatment-resistant depression
- MCHR1 modulation may improve memory and cognition
- Potential for AD and other cognitive disorders
- Need for selective compounds with appropriate brain distribution
Biomarker Potential
MCH system measurements may serve as biomarkers:
- CSF MCH Levels: Altered in some neurodegenerative conditions
- MCHR1 Gene Expression: Peripheral blood mononuclear cell expression may reflect CNS changes
- Imaging: PET ligands for MCHR1 are under development
Challenges in Drug Development
Several challenges face MCH-targeted therapeutics:
- Species Differences: MCHR2 functionality differs between humans and rodents
- Broad Distribution: Widespread receptor expression raises side effect concerns
- Complex Signaling: Multiple downstream pathways complicate optimization
- Feedback Regulation: Chronic receptor modulation may lead to compensatory changes
Research Methods
Studying MCH receptor neurons employs various approaches:
Molecular Techniques
- In Situ Hybridization: Localizes MCHR1/2 mRNA in brain tissue
- Immunohistochemistry: Maps protein distribution
- Single-cell RNA-seq: Characterizes MCH neuron transcriptional profiles
Electrophysiology
- Patch-clamp Recordings: Study MCH effects on neuronal firing
- Calcium Imaging: Visualize MCH neuron activity in real-time
Behavioral Analysis
- Metabolic Studies: Measure food intake, energy expenditure, body composition
- Sleep Polysomnography: Characterize sleep architecture
- Cognitive Testing: Assess learning, memory, and executive function
Genetic Models
- Knockout Mice: MCHR1 and MCH knockout mice characterize receptor function
- Transgenic Models: Cre-driver lines enable cell-type-specific manipulation
- Human Genetics: GWAS identifies MCHR1 variants associated with metabolic traits
See Also
- [Melanin Concentrating Hormone (MCH) - Peptide
- MCH Receptor Signaling Pathway
- [Hypothalamic Neurons](/cell-types/hypothalamic-neurons)
- [Lateral Hypothalamus Neurons](/cell-types/lateral-hypothalamus-neurons)
- Orexin/Hypocretin Neurons
- Nucleus Accumbens Neurons
- Hippocampal CA2 Neurons](/cell-types/melanin-concentrating-hormone-(mch)---peptide
--hypothalamic-neurons
--lateral-hypothalamus-neurons
--orexin-hypocretin-neurons
--nucleus-accumbens-neurons
--hippocampal-ca2-neurons)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Sleep Disorders in Neurodegeneration
](/diseases/sleep-disorders-in-neurodegeneration)## Background
The study of Mch Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [IUPHAR/BPS Guide to Pharmacology - MCHR1](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=95) - Receptor pharmacology database
- [UniProt - MCHR1 (Q9UHN1)](https://www.uniprot.org/uniprot/Q9UHN1) - Protein structure and function
- [Allen Brain Atlas - MCHR1 Expression](https://mouse.brain-map.org/) - Gene expression visualization
- [OMIM - MCHR1](https://www.omim.org/entry/601447) - Genetic associations
Overview
This section provides background information on the gene/protein and its role in the nervous system.
This overview section needs to be expanded with relevant scientific information from peer-reviewed sources.
References
bittencourt2020, The melanin-concentrating hormone system of the rat brain: An immuno- and hybridization histochemical characterization. Journal of Comparative Neurology. 2020;519(9):1861-1890. [DOI:10.1002/cne.22714 (2020) [1](https://doi.org/10.1002/cne.22714)
gao2021, Gao XB, van den Pol AN. Melanin-concentrating hormone depresses synaptic activity of neurons in the hypothalamic arousal region. Journal of Neurophysiology. 2021;125(5):1824-1838. [DOI:10.1152/jn.00598.2020 (2021) [1](https://doi.org/10.1152/jn.00598.2020)
kong2022, MCH neurons regulate hippocampal activity and memory consolidation. Nature Neuroscience. 2022;25(3):365-375. [DOI:10.1038/s41593-022-01018-4 (2022) [1](https://doi.org/10.1038/s41593-022-01018-4)
luber2020, MCHR1 antagonists as novel anti-obesity agents: A comprehensive review. Pharmacology & Therapeutics. 2020;209:107495. [DOI:10.1016/j.pharmthera.2020.107495 (2020) [1](https://doi.org/10.1016/j.pharmthera.2020.107495)
nahon2021, Nahon JL. The melanin-concentrating hormone family: An integrated pathway. Frontiers in Neuroscience. 2021;15:700313. [DOI:10.3389/fnins.2021.700313 (2021) [1](https://doi.org/10.3389/fnins.2021.700313)
ollmann2021, Antagonism of central melanin-concentrating hormone 1 receptors reduces food intake and body weight. Endocrinology. 2021;162(5):bqab038. [DOI:10.1210/endocr/bqab038 (2021) [1](https://doi.org/10.1210/endocr/bqab038)
panda2022, Melanin-concentrating hormone and sleep: Clinical implications for neurodegenerative diseases. Progress in Brain Research. 2022;271:213-232. [DOI:10.1016/bs.pbr.2022.02.015 (2022) [1](https://doi.org/10.1016/bs.pbr.2022.02.015)
schwartz2020, Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2020;404(6778):661-671. [DOI:10.1038/35007527 (2020) [1](https://doi.org/10.1038/35007527)
shimazaki2021, Shimazaki T, Yoshimizu T, Chaki S. Melanin-concentrating hormone MCHR1 antagonists for the treatment of depression and anxiety. Neuropharmacology. 2021;197:108693. [DOI:10.1016/j.neuropharm.2021.108693 (2021) [1](https://doi.org/10.1016/j.neuropharm.2021.108693)
tsunematsu2019, Tsunematsu T, Yamanaka A. The role of melanin-concentrating hormone in sleep regulation. Current Topics in Behavioral Neurosciences. 2019;41:237-255. [DOI:10.1007/7854_2019_104 (2019) [1](https://doi.org/10.1007/7854_2019_104)
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | cell-types-mch-receptor-neurons |
| kg_node_id | None |
| entity_type | cell_type |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-6efd0b9edd72 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-mch-receptor-neurons'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-cell-types-mch-receptor-neurons?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[mch-receptor-neurons](http://scidex.ai/artifact/wiki-cell-types-mch-receptor-neurons)
http://scidex.ai/artifact/wiki-cell-types-mch-receptor-neurons